Conference LibraryGated
Best Pract Res Clin Rheumatol 2026 · CAR-T 'Living drugs' in SLE · Khalili/Askanase
"Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative therapeutic option for patients with severe, refractory autoimmune conditions. Since 2022, several authors have published their experience using CAR T-cell therapy for patients with systemic lupus er…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_verify_wave_3_2026-05-16
- evidence_grade
- A
- category
- car_t_sle_autoimmune
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "review of SLE CAR-T clinical experience · early-stage data · not intended to guide individual patient treatment choices"
- journal
- Best Practice & Research Clinical Rheumatology
- year
- 2026
- authors
- Leila Khalili,Anca Askanase
- abstract_snippet
- "Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative therapeutic option for patients with severe, refractory autoimmune conditions. Since 2022, several authors have published their experience using CAR T-cell therapy for patients with systemic lupus
- pmid
- 41956929
- doi
- 10.1016/j.berh.2026.102141
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.